Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Dentsply ...

NEW YORK, Nov. 28, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Dentsply Sirona Inc. (NASDAQ: XRAY) between December 1, 2022 and November 6, 2024, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 27, 2025.

So what: If you purchased Dentsply common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Dentsply class action, go to https://rosenlegal.com/submit-form/?case_id=31762 or call Phillip Kim, Esq. at 866-767-3653 or email [email protected] for more information. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 13, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, during the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) Dentsply targeted low-income people who did not have access to good oral hygiene education, a dentist, or dental insurance, which often meant patients signing up for Byte, a direct-to-consumer ("DTC") aligner solution, had underlying dental issues that would have made them ineligible for treatment; (2) the push for Byte growth and sales commissions caused sales employees to sell to contraindicated patients; (3) as a result of the above, the Byte patient onboarding workflow did not provide adequate assurance that contraindicated patients did not enter treatment; (4) before and during the Class Period, reports of Byte patient injuries were pouring in; (5) Dentsply knew that its Byte aligners were causing severe patient injuries for years but did little to investigate those injuries or notify the U.S. Food and Drug Administration ("FDA"); (6) Dentsply had no systems in place to notify the FDA of these injuries, which Dentsply is required to do within 30 days of learning of a problem; (7) the FDA had received a sharp uptick in reports of serious injuries from Byte patients; (8) as a result of the above, Dentsply materially overstated the goodwill value of Byte; and (9) as a result of the above, defendants' positive statements about Dentsply's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Dentsply class action, go to https://rosenlegal.com/submit-form/?case_id=31762 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.Phillip Kim, Esq.The Rosen Law Firm, P.A.275 Madison Avenue, 40th FloorNew York, NY 10016Tel: (212) 686-1060Toll Free: (866) 767-3653Fax: (212) 202-3827[email protected]www.rosenlegal.com

SOURCE THE ROSEN LAW FIRM, P. A.

XRAY

XRAY Investors Have Opportunity to Lead Dentsply Sirona Inc. Securities Fraud Lawsuit

<article style="font-family: Arial, sans-serif; line-height: 1.6; color: #333;">
    <h1 style="font-size: 24px; color: #0056b3;">NEW YORK, Nov. 28, 2024 /PRNewswire/</h1>
    <p style="margin: 0; font-size: 16px;">-- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Dentsply Sirona Inc. (NASDAQ: XRAY) between December 1, 2022 and November 6, 2024, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 27, 2025.</p>

    <h2 style="font-size: 20px; color: #333; margin-top: 20px;">So what:</h2>
    <p style="font-size: 16px;">If you purchased Dentsply common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.</p>

    <h2 style="font-size: 20px; color: #333; margin-top: 20px;">What to do next:</h2>
    <p style="font-size: 16px;">To join the Dentsply class action, go to <a href="https://rosenlegal.com/submit-form/?case_id=31762" style="color: #0056b3;">https://rosenlegal.com/submit-form/?case_id=31762</a> or call Phillip Kim, Esq. at <strong style="color: #0056b3;">866-767-3653</strong> or email <a href="mailto:[email protected]" style="color: #0056b3;">[email protected]</a> for more information. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 13, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.</p>

    <h2 style="font-size: 20px; color: #333; margin-top: 20px;">Why Rosen Law:</h2>
    <p style="font-size: 16px;">We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.</p>

    <h2 style="font-size: 20px; color: #333; margin-top: 20px;">Details of the case:</h2>
    <p style="font-size: 16px;">According to the lawsuit, during the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) Dentsply targeted low-income people who did not have access to good oral hygiene education, a dentist, or dental insurance, which often meant patients signing up for Byte, a direct-to-consumer ("DTC") aligner solution, had underlying dental issues that would have made them ineligible for treatment; (2) the push for Byte growth and sales commissions caused sales employees to sell to contraindicated patients; (3) as a result of the above, the Byte patient onboarding workflow did not provide adequate assurance that contraindicated patients did not enter treatment; (4) before and during the Class Period, reports of Byte patient injuries were pouring in; (5) Dentsply knew that its Byte aligners were causing severe patient injuries for years but did little to investigate those injuries or notify the U.S. Food and Drug Administration ("FDA"); (6) Dentsply had no systems in place to notify the FDA of these injuries, which Dentsply is required to do within 30 days of learning of a problem; (7) the FDA had received a sharp uptick in reports of serious injuries from Byte patients; (8) as a result of the above, Dentsply materially overstated the goodwill value of Byte; and (9) as a result of the above, defendants' positive statements about Dentsply's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.</p>

    <p style="font-size: 16px;">To join the Dentsply class action, go to <a href="https://rosenlegal.com/submit-form/?case_id=31762" style="color: #0056b3;">https://rosenlegal.com/submit-form/?case_id=31762</a> or call Phillip Kim, Esq. toll-free at <strong style="color: #0056b3;">866-767-3653</strong> or email <a href="mailto:[email protected]" style="color: #0056b3;">[email protected]</a> for information on the class action.</p>

    <h2 style="font-size: 20px; color: #333; margin-top: 20px;">No Class Has Been Certified.</h2>
    <p style="font-size: 16px;">Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.</p>

    <h2 style="font-size: 20px; color: #333; margin-top: 20px;">Follow us for updates:</h2>
    <p style="font-size: 16px;">on <a href="https://www.linkedin.com/company/the-rosen-law-firm" style="color: #0056b3;">LinkedIn</a>, <a href="https://twitter.com/rosen_firm" style="color: #0056b3;">Twitter</a>, or <a href="https://www.facebook.com/rosenlawfirm/" style="color: #0056b3;">Facebook</a>.</p>

    <p style="font-size: 16px; margin-top: 20px; font-weight: bold;">Attorney Advertising. Prior results do not guarantee a similar outcome.</p>

    <h2 style="font-size: 20px; color: #333; margin-top: 20px;">Contact Information:</h2>
    <p style="font-size: 16px;">Laurence Rosen, Esq.<br />
    Phillip Kim, Esq.<br />
    The Rosen Law Firm, P.A.<br />
    275 Madison Avenue, 40th Floor<br />
    New York, NY 10016<br />
    Tel: <strong style="color: #0056b3;">(212) 686-1060</strong><br />
    Toll Free: <strong style="color: #0056b3;">(866) 767-3653</strong><br />
    Fax: (212) 202-3827<br />
    Email: <a href="mailto:[email protected]" style="color: #0056b3;">[email protected]</a><br />
    Website: <a href="http://www.rosenlegal.com" style="color: #0056b3;">www.rosenlegal.com</a></p>

    <p style="font-size: 16px; margin-top: 20px;">SOURCE THE ROSEN LAW FIRM, P. A.</p>
</article>

Class action lawsuit filed for Dentsply Sirona Inc. shareholders.
Lawsuit alleges misleading statements about Byte aligner treatments.
Investors may seek compensation for damages caused by false information.
Lawsuit claims Dentsply ignored severe patient injuries and FDA reports.

XRAY Investors Have Opportunity to Lead Dentsply Sirona Inc. Securities Fraud Lawsuit

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

Legal

Related News